Allan E. Rubenstein, MD, Chairman, a world leader in NF, founded and was the CEO of NexGenix Pharma, a HSP90 inhibitor based company. Currently is vice-chairman and lead director of Cooper Companies (NYSE: COO). Founded the Children’s Tumor Foundation and established the first interdisciplinary NF clinic in the world. Worked with DoD to setup the NF research grant funding program. He has been recognized in Who's Who in the East and Who's Who in

Jeffrey Stebbins, PhD, Head Biology/Pharmacology, led the team that discovered a clinical candidate for the treatment of obesity and Bayer, BAY 74-4113.

Sridhar Prasad, PhD, is the VP of Research, led crystallography teams for multiple drug discovery programs, including Nesina, a Type 2 diabetes drug, recently approved by FDA and MK-4965, a Merck second generation HIV-1 AIDS drug currently in clinical trials.

A widely-published and decorated materials scientist with extensive entrepreneurial experience, through multiple exits, as a company founder, CSO, SVP of Business Development and CEO.

Professor of Ophthalmology, Joint Professor of Biochemistry. Univ. of Missouri, Columbia, MO.
http://biochem.missouri.edu/faculty/faculty-members/sharmak/index.php

Marco Giovannini, M.D., Ph.D., is the head of the Department of Neural Tumor Research at House Research Institute, Los Angles, CA. A native of Italy, Dr. Giovannini most recently served as Director of the Functional Genomics and Tumor Research Laboratory at the University of Paris VII in France and as chief scientific officer at NexGenix Pharmaceuticals in Burlingame, California. Marco Giovannini earned his medical degree at the University of Bol

Distinguished Chair of Eye Health
Chair, Hyderabad Eye Institute
Founder, L V Prasad Eye Institute

Gullapalli N Rao returned to India in 1986 to establish L V Prasad Eye Institute, after a successful career in the United States as an academic ophthalmologist. Dr Rao received his basic medical education in Guntur, Andhra Pradesh, and completed his postgraduate training in ophthalmology at the All India Institute for Medical Sciences, New Delh